Bouchi Ryotaro, Ohara Norihiko, Asakawa Masahiro, Nakano Yujiro, Takeuchi Takato, Murakami Masanori, Sasahara Yuriko, Numasawa Mitsuyuki, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro
Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Center for Medical Welfare and Liaison Services, Tokyo Medical and Dental University, Tokyo, Japan.
Cardiovasc Diabetol. 2016 Jan 21;15:10. doi: 10.1186/s12933-016-0335-3.
We aimed to investigate whether visceral adiposity could modify the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes.
This cross-sectional study examines the interaction of visceral adiposity with increased blood pressure on arterial stiffness and albuminuria. 638 patients with type 2 diabetes (mean age 64 ± 12 years; 40 % female) were enrolled. Visceral fat area (VFA, cm(2)) was assessed by a dual-impedance analyzer, whereby patients were divided into those with VFA < 100 (N = 341) and those with VFA ≥ 100 (N = 297). Albuminuria was measured in a single 24-h urine collection (UAE, mg/day) and brachial-ankle pulse wave velocity (ba-PWV, cm/s) was used for the assessment of arterial stiffening. Linear regression analyses were used to investigate the association of systolic blood pressure (SBP) and VFA with UAE and baPWV.
Patients with VFA ≥ 100 were significantly younger, had higher SBP, HbA1c, triglycerides, UAE, alanine aminotransferase, C-reactive protein and lower high-density lipoprotein and shorter duration of diabetes than those with VFA < 100. SBP was significantly and almost equivalently associated with ba-PWV both in VFA < 100 (standardized β 0.224, p = 0.001) and VFA ≥ 100 (standardized β 0.196, p = 0.004) patients in the multivariate regression analysis adjusting for covariates including age, gender, HbA1c, diabetic complications and the use of insulin and anti-hypertensive agents. By contrast, the association of SBP with UAE was stronger in patients with VFA ≥ 100 (standardized β 0.263, p = 0.001) than that in patients with VFA < 100 (standardized β 0.140, p = 0.080) in the multivariate regression model. In the whole cohort, the significant interaction between SBP and VFA on UAE (standardized β 0.172, p = 0.040) but not on ba-PWV (standardized β -0.008, p = 0.916) was observed.
The effect of increased blood pressure on arterial stiffness is almost similar in type 2 diabetic patients with both low and high visceral adiposity, while its association with albuminuria is stronger in the latter.
我们旨在研究内脏脂肪过多是否会改变2型糖尿病患者血压对动脉僵硬度和蛋白尿的影响。
这项横断面研究考察了内脏脂肪过多与血压升高在动脉僵硬度和蛋白尿方面的相互作用。纳入了638例2型糖尿病患者(平均年龄64±12岁;40%为女性)。通过双阻抗分析仪评估内脏脂肪面积(VFA,cm²),据此将患者分为VFA<100(N=341)和VFA≥100(N=297)两组。通过单次24小时尿液收集测量蛋白尿(UAE,mg/天),并使用臂踝脉搏波速度(ba-PWV,cm/s)评估动脉僵硬度。采用线性回归分析研究收缩压(SBP)和VFA与UAE及baPWV之间的关联。
与VFA<100的患者相比,VFA≥100的患者明显更年轻,SBP、糖化血红蛋白、甘油三酯、UAE、丙氨酸转氨酶、C反应蛋白更高,高密度脂蛋白更低,糖尿病病程更短。在多变量回归分析中,校正包括年龄、性别、糖化血红蛋白、糖尿病并发症以及胰岛素和抗高血压药物使用等协变量后,SBP与ba-PWV在VFA<100(标准化β0.224,p=0.001)和VFA≥100(标准化β0.196,p=0.004)的患者中均显著且几乎同等相关。相比之下,在多变量回归模型中,SBP与UAE的关联在VFA≥100的患者中(标准化β0.263,p=0.001)比在VFA<100的患者中(标准化β0.140,p=0.080)更强。在整个队列中,观察到SBP和VFA在UAE方面存在显著交互作用(标准化β0.172,p=0.040),但在ba-PWV方面不存在(标准化β-0.008,p=0.916)。
血压升高对动脉僵硬度的影响在低内脏脂肪和高内脏脂肪的2型糖尿病患者中几乎相似,而其与蛋白尿的关联在后者中更强。